IMDX vs CDNA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 29, 2026

IMDX

37.5
AI Score
VS
IMDX Wins

CDNA

35.6
AI Score

Investment Advisor Scores

IMDX

38score
Recommendation
SELL

CDNA

36score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric IMDX CDNA Winner
Revenue 271,000 249.65M CDNA
Net Income -15.55M 113.44M CDNA
Net Margin -5738.0% 45.4% CDNA
Operating Income -15.81M 114.42M CDNA
ROE 73.0% 26.7% IMDX
ROA -52.8% 21.3% CDNA
Total Assets 29.44M 532.99M CDNA
Cash 17.76M 373.64M CDNA
Current Ratio 2.00 4.58 CDNA
Free Cash Flow -18.30M 29.26M CDNA

Relative Price Performance (Last 90 Days)

IMDX 1M: -10.5% · 3M: -40.2% CDNA 1M: +36.1% · 3M: +128.3%

Current Technical Phase

IMDX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -10.4%), weak momentum, RSI 40

RSI (14): 39.5 · Price: $3.44

CDNA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (24.8% over 20 days), RSI 81

RSI (14): 80.8 · Price: $66.66

Fundamentals Snapshot

Metric IMDX CDNA
Market Cap — —
Forward P/E -4.5 48.9
Trailing P/E — 31.1
Revenue (TTM) — —
Revenue Growth -0.5% 0.5%
Gross Margin 0.5% 0.7%
Operating Margin -38.2% 0.0%
EPS -1.62 2.06
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, IMDX is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.